Oxford Cannabinoid Technologies Holdings Plc
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines in the United Kingdom. Its lead drug candidate consists of OCT461201, a cannabinoid like new chemical entity, which is in phase I clinical trial for potential therapy to peripheral neuropathies and irritable bowel syndrome.… Read more
Oxford Cannabinoid Technologies Holdings Plc (OCTHF) - Net Assets
Latest net assets as of October 2023: $1.95 Million USD
Based on the latest financial reports, Oxford Cannabinoid Technologies Holdings Plc (OCTHF) has net assets worth $1.95 Million USD as of October 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.79 Million) and total liabilities ($840.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.95 Million |
| % of Total Assets | 69.89% |
| Annual Growth Rate | N/A |
| 5-Year Change | 118.83% |
| 10-Year Change | N/A |
| Growth Volatility | 1133.05 |
Oxford Cannabinoid Technologies Holdings Plc - Net Assets Trend (2018–2023)
This chart illustrates how Oxford Cannabinoid Technologies Holdings Plc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Oxford Cannabinoid Technologies Holdings Plc (2018–2023)
The table below shows the annual net assets of Oxford Cannabinoid Technologies Holdings Plc from 2018 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-04-30 | $3.91 Million | -60.05% |
| 2022-04-30 | $9.79 Million | -31.10% |
| 2021-04-30 | $14.21 Million | +2562.69% |
| 2020-04-30 | $533.81K | -70.14% |
| 2019-04-30 | $1.79 Million | +566.78% |
| 2018-04-30 | $-382.96K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Oxford Cannabinoid Technologies Holdings Plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1859364100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (April 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $9.60 Million | 245.52% |
| Other Comprehensive Income | $2.16 Million | 55.14% |
| Other Components | $11.88 Million | 303.63% |
| Total Equity | $3.91 Million | 100.00% |
Oxford Cannabinoid Technologies Holdings Plc Competitors by Market Cap
The table below lists competitors of Oxford Cannabinoid Technologies Holdings Plc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PExA AB (publ)
F:FA0
|
$2.05 Million |
|
Dangee Dums Limited
NSE:DANGEE
|
$2.05 Million |
|
Hanil Vacuum Co. Ltd
KQ:123840
|
$2.05 Million |
|
Hwa Tai Industries Bhd
KLSE:8478
|
$2.05 Million |
|
JET CONTRACTORS
BC:JET-CONTRACTORS
|
$2.05 Million |
|
X2M Connect Ltd
AU:X2M
|
$2.05 Million |
|
Talis Biomedical Corp
PINK:TLIS
|
$2.04 Million |
|
CARLSON INV. ZY 13
F:2HB
|
$2.04 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Oxford Cannabinoid Technologies Holdings Plc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 9,793,028 to 3,911,828, a change of -5,881,200 (-60.1%).
- Net loss of 5,945,050 reduced equity.
- Other comprehensive income increased equity by 63,850.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-5.95 Million | -151.98% |
| Other Comprehensive Income | $63.85K | +1.63% |
| Total Change | $- | -60.05% |
Book Value vs Market Value Analysis
This analysis compares Oxford Cannabinoid Technologies Holdings Plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.69x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-04-30 | $0.00 | $0.00 | x |
| 2019-04-30 | $0.00 | $0.00 | x |
| 2020-04-30 | $0.00 | $0.00 | x |
| 2021-04-30 | $0.01 | $0.00 | x |
| 2022-04-30 | $0.01 | $0.00 | x |
| 2023-04-30 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Oxford Cannabinoid Technologies Holdings Plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -151.98%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -537.99%
- • Asset Turnover: 0.25x
- • Equity Multiplier: 1.15x
- Recent ROE (-151.98%) is above the historical average (-154.91%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | -146.39% | 0.00% | 0.00x | 1.31x | $-2.80 Million |
| 2020 | -400.95% | 0.00% | 0.00x | 2.46x | $-2.19 Million |
| 2021 | -22.71% | 0.00% | 0.00x | 1.07x | $-4.65 Million |
| 2022 | -52.49% | 0.00% | 0.00x | 1.21x | $-6.12 Million |
| 2023 | -151.98% | -537.99% | 0.25x | 1.15x | $-6.34 Million |
Industry Comparison
This section compares Oxford Cannabinoid Technologies Holdings Plc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $59,082,939
- Average return on equity (ROE) among peers: -341.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Oxford Cannabinoid Technologies Holdings Plc (OCTHF) | $1.95 Million | -146.39% | 0.43x | $2.05 Million |
| Aadi Bioscience Inc (AADI) | $-124.24K | 0.00% | 0.00x | $17.03 Million |
| America Great Health (AAGH) | $-992.37K | 0.00% | 0.00x | $2.12 Million |
| Ascentage Pharma Group International (AAPG) | $70.63 Million | -1310.51% | 34.40x | $2.25 Billion |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $59.18 Million |
| ABIVAX Société Anonyme (AAVXF) | $196.01 Million | -75.37% | 0.67x | $377.86 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $738.02 Million |
| Abeona Therapeutics Inc (ABEO) | $489.00K | -1919.02% | 38.85x | $202.79 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $188.78 Million | -22.70% | 0.04x | $108.65 Million |
| Abpro Holdings, Inc. (ABP) | $-22.46 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $176.18 Million | -62.76% | 0.23x | $345.85 Million |